Correction: Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes - Report - MDSpire

Correction: Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes

  • By

  • Ling Xiang

  • Mingmin Zhu

  • Zi Yan

  • Zhijin Geng

  • Yuankai Zhou

  • Zhongming Sun

  • Dandan Miao

  • Yong Zhang

  • Jinyi Zhou

  • Enchun Pan

  • Wen Hu

  • July 2, 2026

  • 0 min

Share

Correction: Reevaluation of Mortality Risk in Young-Onset Type 2 Diabetes

Overview

This correction addresses the affiliations of authors in a study on mortality risk in female patients with young-onset type 2 diabetes. It clarifies the correct affiliations for author Jinyi Zhou and updates the erroneous information regarding another author's affiliation.

Background

Young-onset type 2 diabetes (YOD), defined as diagnosis before age 40, is associated with a more aggressive disease course and higher complication risks compared to later-onset diabetes.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

  • Correction of author affiliations for Jinyi Zhou in the study on mortality risk.
  • Removal of incorrect affiliation for Jinyi Zhou and addition of the correct one.
  • Clarification of the erroneous departmental affiliation for another author.
  • The original article has been updated to reflect these corrections.

Clinical Implications

Accurate author affiliation is essential for the credibility of research findings.

Conclusion

This correction ensures the integrity of the published research on mortality risk in young-onset type 2 diabetes among female patients.

Related Resources & Content

  1. Xiang L, Zhu M, Yan Z, et al., Front. Endocrinol., 2026 -- Correction on Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes
  2. Frontiers in Endocrinology — Age at type 2 diabetes onset, HOMA-derived indices and risks of diabetic retinopathy: a real-world cross-sectional study
  3. European Journal of Preventive Cardiology — Cardiovascular Risk in Diabetes: An Ongoing Evolution
  4. Frontiers in Endocrinology — Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry study
  5. The Journal of Clinical Endocrinology & Metabolism — Creation and Assessment of a Personalized Diabetes Risk Prediction Model Incorporating Tailored Preventive Intervention Outcomes
  6. Risk factors of early-onset type 2 diabetes: A systematic review and meta-analysis - Shengying Hu, Yizhu Zhang, Angela C. Y. Poon, Yan Ji, Botian Hou, Chenye Zhang, Hongyu Sun, Yumei Sun, 2025
  7. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 - PMC
  8. Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials - PMC

Original Source(s)

Related Content